At 24 weeks, 32 and 29 percent of patients in the 9-mg and 18-mg groups had clinical benefit.

Annual screening appears to provide the greatest benefit and lowest risk.

Researchers found that historical redlining and contemporary mortgage discrimination were associated with breast cancer outcomes, but associations varied by race.

Researchers weighed the evidence in the literature that supports nipple-areola complex restoration with tattoo in women who have undergone breast reconstruction after cancer treatment.

New research suggests that hypofractionated radiotherapy and conventional fractionated radiotherapy largely produce similar outcomes in patients who have undergone breast cancer surgery.

Patients receiving alpelisib for advanced breast cancer may be at risk of developing diabetic ketoacidosis, data suggest.

In a cohort of 25 women newly diagnosed with breast cancer, 24 cancers were identified with PEM.

Invasive breast cancer incidence among US women aged 20 to 49 years increased from 2000 to 2019, data show.

Most women with breast cancer do not talk with clinicians about sexual dysfunction that occurs during or after cancer treatment, a survey suggests.

Interval breast cancers and screen-detected breast cancers have distinct genetic profiles, according to researchers.